Found 23 matching trials
Autologous Atrial Appendage Derived Cells in the Treatment of Heart Failure NA This study aims to evaluate the safety and clinical feasibility of epicardi...
Show More Learn More & Join Trial
A Study of SmartFlow Magnetic Resonance (MR) Compatible Ventricular Cannula for Administering Eladocagene Exuparvovec to Pediatric Participants PHASE2 This study will have a trial phase, extension phase, and a long-term extens...
Show More Status
Active Not Recruiting
Location
Boston Children's Hospital
Learn More & Join Trial
Follow Up Safety Study of SCH 420814 in Subjects With Parkinson's Disease (P05175) PHASE2 The purpose of this study is to assess the long term safety of SCH 420814 (...
Show More Location
Multiple Locations
Learn More & Join Trial
A Clinical Trial for Treatment of Aromatic L-amino Acid Decarboxylase (AADC) Deficiency Using AAV2-hAADC - An Expansion PHASE2 This clinical trial expansion is to offer patients, who are not enrolled in...
Show More Location
National Taiwan University Hospital
Learn More & Join Trial
A Single-Stage, Adaptive, Open-label, Dose Escalation Safety and Efficacy Study of AADC Deficiency in Pediatric Patients PHASE1 The overall objective of this study is to determine the safety and efficacy...
Show More Location
University of California San Francisco, Benioff Children's Hospital
Learn More & Join Trial
A Trial to Evaluate Safety and Efficacy of a Product Named VGN-R09b in Severe AADC Deficiency PHASE2 This trial includes dose-escalating part (phase 1) and dose confirming part...
Show More Status
Active Not Recruiting
Learn More & Join Trial
AAV2-hAADC for Parkinson's Disease (PDCS-01) PHASE1 This study is looking at whether a gene therapy called AAV2-hAADC is safe a...
Show More Location
The Ohio State University
Learn More & Join Trial
VY-AADC02 for Parkinson's Disease With Motor Fluctuations (RESTORE-1) PHASE1 The objective of this study is to assess the safety of VY-AADC02 in partici...
Show More Learn More & Join Trial
Efficacy, Safety and Tolerability Study of ND0612 vs. Oral Immediate Release Levodopa/Carbidopa (IR-LD/CD) in Subjects With Parkinson's Disease Experiencing Motor Fluctuations PHASE3 This is a multi-center, randomized, double-blind, double-dummy, active cont...
Show More Status
Active Not Recruiting
Learn More & Join Trial
Early ParkinSon wIth L-DOPA/DDCI and OpicapoNe (EPSILON Study) PHASE3 Opicapone (OPC) is a third generation catechol O methyltransferase (COMT) i...
Show More Location
Medical Centre "Asklepii", OOD
Learn More & Join Trial